171 results
Page 5 of 9
424B5
8069iyyz
25 Oct 13
Prospectus supplement for primary offering
12:00am
424B3
ynzwf
24 Oct 13
Prospectus supplement
12:00am
8-K
EX-99.1
ejbkqjzx04iq6ujx0
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-10.1
y4jlbgewo xcgajgame
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
424B5
1t95hl
27 Jul 12
Prospectus supplement for primary offering
12:00am
424B3
vnu5 bjhgon26e8ij
26 Jul 12
Prospectus supplement
12:00am
SC TO-T/A
EX-99
eywksw
23 Jul 12
Third party tender offer statement (amended)
12:00am